000 01359 a2200385 4500
005 20250517094348.0
264 0 _c20180326
008 201803s 0 0 eng d
022 _a2045-2322
024 7 _a10.1038/srep25615
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWang, Wei
245 0 0 _aNetwork Meta-Analysis of the Effectiveness of Neoadjuvant Endocrine Therapy for Postmenopausal, HR-Positive Breast Cancer.
_h[electronic resource]
260 _bScientific reports
_c05 2016
300 _a25615 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents, Hormonal
_xtherapeutic use
650 0 4 _aAromatase Inhibitors
_xtherapeutic use
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aNeoadjuvant Therapy
650 0 4 _aNetwork Meta-Analysis
650 0 4 _aPostmenopause
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aReceptors, Steroid
_xmetabolism
650 0 4 _aTreatment Outcome
700 1 _aLiu, Chenghao
700 1 _aZhou, Wenbin
700 1 _aXia, Tiansong
700 1 _aXie, Hui
700 1 _aWang, Shui
773 0 _tScientific reports
_gvol. 6
_gp. 25615
856 4 0 _uhttps://doi.org/10.1038/srep25615
_zAvailable from publisher's website
999 _c26015533
_d26015533